Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

M. Matsuo; H. Sakurai; Y. Ueno; O. Ohtani; I. Saiki

doi:10.1111/j.1349-7006.2006.00187.x

Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

M. Matsuo, H. Sakurai, Y. Ueno, O. Ohtani, I. Saiki

研究成果: ジャーナルへの寄稿 › コメント/討論

本文言語	英語
ページ（範囲）	242
ページ数	1
ジャーナル	Cancer Science
巻	97
号	3
DOI	https://doi.org/10.1111/j.1349-7006.2006.00187.x
出版ステータス	出版済み - 2006/03

ASJC Scopus 主題領域

腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1111/j.1349-7006.2006.00187.x

引用スタイル

@article{cb271217831e4b8d8f77048df36b9f10,

title = "Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))",

author = "M. Matsuo and H. Sakurai and Y. Ueno and O. Ohtani and I. Saiki",

year = "2006",

month = mar,

doi = "10.1111/j.1349-7006.2006.00187.x",

language = "英語",

volume = "97",

pages = "242",

journal = "Cancer Science",

issn = "1347-9032",

publisher = "Wiley-Blackwell",

number = "3",

}

Matsuo, M, Sakurai, H, Ueno, Y, Ohtani, O & Saiki, I 2006, 'Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))', Cancer Science, vol. 97, no. 3, pp. 242. https://doi.org/10.1111/j.1349-7006.2006.00187.x

Erratum: Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162)). / Matsuo, M.; Sakurai, H.; Ueno, Y. その他.
In: Cancer Science, Vol. 97, No. 3, 03.2006, p. 242.

研究成果: ジャーナルへの寄稿 › コメント/討論

TY - JOUR

T1 - Erratum

T2 - Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib (Cancer Science (2006) vol. 97 (155-162))

AU - Matsuo, M.

AU - Sakurai, H.

AU - Ueno, Y.

AU - Ohtani, O.

AU - Saiki, I.

PY - 2006/3

Y1 - 2006/3

UR - http://www.scopus.com/inward/record.url?scp=33645992099&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2006.00187.x

DO - 10.1111/j.1349-7006.2006.00187.x

M3 - コメント/討論

AN - SCOPUS:33645992099

SN - 1347-9032

VL - 97

SP - 242

JO - Cancer Science

JF - Cancer Science

IS - 3

ER -